<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83762">
  <stage>Registered</stage>
  <submitdate>29/03/2009</submitdate>
  <approvaldate>21/05/2009</approvaldate>
  <actrnumber>ACTRN12609000318280</actrnumber>
  <trial_identification>
    <studytitle>A comparison of the success of Single vs Triple Injection for Ultrasound Guided Infraclavicular Block in patients undergoing wrist and forearm surgery</studytitle>
    <scientifictitle>Optimising Ultrasound Guided Infraclavicular Brachial Plexus Block for Ambulatory Hand Surgery: single vs. triple point injection</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Hand09</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Surgical anaesthesia during minor wrist and hand surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Single point injection (deep to axillary artery) for ultrasound guided infraclavicular block with 30 mL lignicaine 2%, one-off treatment lasting 10 minutes, used in conjunction with ultrasound machine and transducer.</interventions>
    <comparator>Triple point injection (around the 3 cords of the brachial plexus) for ultrasound guided infraclavicular block (30 mL lignocaine 2%, one-off treatment lasting 10 minutes, used in conjunction with Ultrasound machine and transducer</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Block effectiveness after ultrasound guided infraclavicular block assessed by pin-prick sensation in the 4 distal nerve territories</outcome>
      <timepoint>Immediately prior to and immediately following block placement and at 10 minute intervals until block complete</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Block placement time</outcome>
      <timepoint>During block placement</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Surgical Anaesthesia: adequacy of anesthesia to conduct the surgical procedure. It will be assessed by the surgeon based on whether the anaesthesia is satisfactory or not.</outcome>
      <timepoint>1-2 hour post procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Procedural pain assessed by direct patient interrogation</outcome>
      <timepoint>At 10 minutes after injection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients requiring surgical anaesthesia for minor hand or wrist surgery under the care of the two investigators</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient refusal for brachial plexus block.  2. Known neuropathy involving the arm undergoing surgery.  3.  Known allergy to amide local anaesthetic drugs.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Initial invitation to participate in the study will occur in the surgeon's rooms.  Approximately one week prior to surgery, patients will be contacted by a research assistant to provide further informed consent.  Written informed consent will be obtained from all patients.  Assignment of the patient to single point or triple point injection will be delivered in a sealed opaque envelope.</concealment>
    <sequence>A computerised random number generator will be used to assign the patient to one of the 2 groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2009</anticipatedstartdate>
    <actualstartdate>1/04/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>27/01/2010</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Michael Fredrickson</primarysponsorname>
    <primarysponsoraddress>Anaesthesia Institute
P O Box 109  199
Newmarket
Auckland 1149</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Dr Michael Fredrickson</fundingname>
      <fundingaddress>Anaesthesia Institute P O Box 109 199 Newmarket Auckland 1149</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>If the primary hypothesis is confirmed, this study will provide evidence supporting the use of a single point injection for infraclavicular block.  Increased exposure of the techniques may promote their uptake in this setting.</summary>
    <trialwebsite />
    <publication>N/A</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Y Regional Ethics Committee</ethicname>
      <ethicaddress>P O Box 1031
Hamilton
Waikato Mail Centre 3240</ethicaddress>
      <ethicapprovaldate>21/05/2009</ethicapprovaldate>
      <hrec>NTY/09/03/028</hrec>
      <ethicsubmitdate>9/03/2009</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Linda White</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+64 9 522 1117</phone>
      <fax>+64 9 522 1127</fax>
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Michael Fredrickson</name>
      <address>Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149</address>
      <phone>+6495221117</phone>
      <fax />
      <email>anaesthesiainstitute@yahoo.com</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>